Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Phosphatidylinositol 3-Kinases | 41 | 2022 | 2859 | 4.570 |
Why?
|
PTEN Phosphohydrolase | 18 | 2023 | 1114 | 3.070 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 23 | 2021 | 896 | 2.880 |
Why?
|
Cyclin-Dependent Kinase 4 | 8 | 2024 | 555 | 2.110 |
Why?
|
Cyclin-Dependent Kinase 6 | 5 | 2022 | 345 | 2.000 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 8 | 2021 | 76 | 1.710 |
Why?
|
Phosphatidylinositol 3-Kinase | 5 | 2023 | 126 | 1.680 |
Why?
|
Breast Neoplasms | 29 | 2024 | 20992 | 1.350 |
Why?
|
Protein Kinase Inhibitors | 14 | 2024 | 5638 | 1.330 |
Why?
|
Cell Transformation, Neoplastic | 14 | 2018 | 2823 | 1.220 |
Why?
|
Mammary Neoplasms, Animal | 2 | 2023 | 124 | 1.180 |
Why?
|
Signal Transduction | 46 | 2024 | 23335 | 1.060 |
Why?
|
TOR Serine-Threonine Kinases | 8 | 2018 | 2056 | 1.050 |
Why?
|
Neoplasms | 22 | 2022 | 21986 | 0.970 |
Why?
|
Class Ib Phosphatidylinositol 3-Kinase | 1 | 2024 | 43 | 0.910 |
Why?
|
Pentose Phosphate Pathway | 1 | 2024 | 126 | 0.900 |
Why?
|
Receptor, erbB-2 | 10 | 2023 | 2552 | 0.890 |
Why?
|
Proto-Oncogene Proteins c-akt | 13 | 2024 | 2443 | 0.880 |
Why?
|
Morpholines | 9 | 2019 | 580 | 0.870 |
Why?
|
Mice | 72 | 2024 | 81066 | 0.850 |
Why?
|
Drug Resistance, Neoplasm | 13 | 2024 | 5253 | 0.850 |
Why?
|
Protein Isoforms | 7 | 2020 | 1694 | 0.850 |
Why?
|
Multiprotein Complexes | 4 | 2018 | 1119 | 0.840 |
Why?
|
Hamartoma Syndrome, Multiple | 2 | 2013 | 114 | 0.820 |
Why?
|
Cell Cycle | 8 | 2024 | 2929 | 0.810 |
Why?
|
Cyclin-Dependent Kinases | 4 | 2024 | 654 | 0.800 |
Why?
|
Protein Biosynthesis | 3 | 2018 | 2106 | 0.790 |
Why?
|
Aminopyridines | 7 | 2019 | 564 | 0.780 |
Why?
|
Cell Line, Tumor | 33 | 2024 | 16881 | 0.750 |
Why?
|
Mammary Neoplasms, Experimental | 5 | 2023 | 507 | 0.750 |
Why?
|
Brain Neoplasms | 10 | 2023 | 8981 | 0.750 |
Why?
|
Mitosis | 3 | 2023 | 1186 | 0.730 |
Why?
|
Animals | 87 | 2024 | 167718 | 0.730 |
Why?
|
Gene Expression Regulation, Neoplastic | 14 | 2024 | 8503 | 0.680 |
Why?
|
Ovarian Neoplasms | 5 | 2023 | 4872 | 0.670 |
Why?
|
Immune Evasion | 1 | 2023 | 362 | 0.670 |
Why?
|
Eukaryotic Initiation Factors | 2 | 2016 | 86 | 0.670 |
Why?
|
Cell Proliferation | 18 | 2024 | 10405 | 0.670 |
Why?
|
Antineoplastic Agents | 17 | 2022 | 13597 | 0.650 |
Why?
|
RNA-Binding Proteins | 3 | 2018 | 1896 | 0.640 |
Why?
|
BRCA1 Protein | 3 | 2022 | 1147 | 0.620 |
Why?
|
Neoplastic Stem Cells | 2 | 2024 | 1346 | 0.610 |
Why?
|
Mammary Glands, Animal | 3 | 2017 | 271 | 0.590 |
Why?
|
Hematopoiesis | 3 | 2019 | 2045 | 0.580 |
Why?
|
ADP-Ribosylation Factor 1 | 1 | 2016 | 43 | 0.540 |
Why?
|
Ribosomal Proteins | 1 | 2018 | 363 | 0.530 |
Why?
|
Molecular Targeted Therapy | 4 | 2022 | 2796 | 0.520 |
Why?
|
Receptor, trkB | 1 | 2016 | 124 | 0.510 |
Why?
|
Isoenzymes | 5 | 2015 | 1686 | 0.500 |
Why?
|
Adaptor Proteins, Signal Transducing | 5 | 2020 | 2891 | 0.500 |
Why?
|
Small Molecule Libraries | 1 | 2020 | 723 | 0.480 |
Why?
|
Leukemia, Myelomonocytic, Juvenile | 1 | 2014 | 25 | 0.460 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2024 | 3599 | 0.460 |
Why?
|
Epithelial Cells | 7 | 2017 | 3664 | 0.440 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2019 | 1170 | 0.440 |
Why?
|
Transcription, Genetic | 2 | 2018 | 7588 | 0.430 |
Why?
|
Mammary Glands, Human | 2 | 2005 | 203 | 0.430 |
Why?
|
Muscle Development | 1 | 2015 | 259 | 0.430 |
Why?
|
Immunity | 1 | 2018 | 997 | 0.410 |
Why?
|
Phosphorylation | 11 | 2019 | 8296 | 0.410 |
Why?
|
Apoptosis | 7 | 2024 | 9466 | 0.400 |
Why?
|
Oncogene Proteins | 3 | 2018 | 719 | 0.390 |
Why?
|
Genes, ras | 2 | 2014 | 654 | 0.390 |
Why?
|
Astrocytoma | 1 | 2016 | 775 | 0.390 |
Why?
|
Mice, Nude | 10 | 2018 | 3600 | 0.390 |
Why?
|
Antigens, Polyomavirus Transforming | 3 | 2007 | 257 | 0.380 |
Why?
|
Immunotherapy | 3 | 2023 | 4641 | 0.370 |
Why?
|
Enzyme Inhibitors | 7 | 2019 | 3709 | 0.370 |
Why?
|
Polyomavirus | 2 | 2012 | 234 | 0.360 |
Why?
|
Carrier Proteins | 3 | 2018 | 4937 | 0.360 |
Why?
|
Membrane Proteins | 6 | 2018 | 7840 | 0.350 |
Why?
|
Glioblastoma | 3 | 2020 | 3480 | 0.340 |
Why?
|
Xenograft Model Antitumor Assays | 10 | 2024 | 3573 | 0.340 |
Why?
|
Gene Dosage | 2 | 2013 | 1218 | 0.340 |
Why?
|
Tumor Microenvironment | 6 | 2023 | 3839 | 0.340 |
Why?
|
Anoikis | 1 | 2009 | 48 | 0.330 |
Why?
|
Myeloproliferative Disorders | 1 | 2015 | 606 | 0.330 |
Why?
|
Gene Expression Profiling | 6 | 2018 | 9403 | 0.330 |
Why?
|
Humans | 90 | 2024 | 757566 | 0.330 |
Why?
|
Receptors, Estrogen | 2 | 2024 | 2208 | 0.320 |
Why?
|
Disease Models, Animal | 13 | 2019 | 18114 | 0.320 |
Why?
|
Pro-Opiomelanocortin | 3 | 2015 | 140 | 0.310 |
Why?
|
RNA | 1 | 2018 | 2716 | 0.310 |
Why?
|
Astrocytes | 1 | 2016 | 1337 | 0.310 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2016 | 1594 | 0.300 |
Why?
|
Estrogen Receptor alpha | 3 | 2018 | 580 | 0.300 |
Why?
|
Immunohistochemistry | 7 | 2019 | 11063 | 0.300 |
Why?
|
Neoplasm Transplantation | 6 | 2017 | 2013 | 0.300 |
Why?
|
Fibroblasts | 6 | 2016 | 4087 | 0.290 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 5272 | 0.290 |
Why?
|
Leukemia | 1 | 2015 | 1521 | 0.290 |
Why?
|
Hematopoietic Stem Cells | 2 | 2019 | 3383 | 0.280 |
Why?
|
Oncogene Protein v-akt | 4 | 2019 | 129 | 0.270 |
Why?
|
Glucose | 6 | 2022 | 4336 | 0.270 |
Why?
|
Phthalazines | 3 | 2018 | 382 | 0.270 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2022 | 697 | 0.270 |
Why?
|
Mice, Knockout | 13 | 2019 | 14345 | 0.260 |
Why?
|
Proto-Oncogene Proteins c-myc | 3 | 2024 | 989 | 0.260 |
Why?
|
Camptothecin | 3 | 2023 | 589 | 0.260 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2018 | 11709 | 0.260 |
Why?
|
Alternative Splicing | 3 | 2018 | 1091 | 0.250 |
Why?
|
Mice, SCID | 4 | 2016 | 2625 | 0.250 |
Why?
|
Membrane Glycoproteins | 1 | 2016 | 3705 | 0.250 |
Why?
|
Enzyme Activation | 6 | 2019 | 3593 | 0.250 |
Why?
|
Female | 46 | 2024 | 389943 | 0.240 |
Why?
|
Mice, Transgenic | 11 | 2018 | 9514 | 0.240 |
Why?
|
Insulin | 2 | 2010 | 6578 | 0.240 |
Why?
|
RNA, Messenger | 2 | 2018 | 12761 | 0.230 |
Why?
|
Endometrial Neoplasms | 1 | 2013 | 1356 | 0.230 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2009 | 2913 | 0.220 |
Why?
|
Ventromedial Hypothalamic Nucleus | 2 | 2016 | 46 | 0.220 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3752 | 0.220 |
Why?
|
Models, Biological | 7 | 2018 | 9459 | 0.210 |
Why?
|
Cells, Cultured | 10 | 2021 | 18936 | 0.210 |
Why?
|
Tankyrases | 1 | 2022 | 13 | 0.210 |
Why?
|
Cell Line, Transformed | 2 | 2018 | 869 | 0.210 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2022 | 1728 | 0.200 |
Why?
|
Cyclic ADP-Ribose | 1 | 2021 | 16 | 0.200 |
Why?
|
Leptin | 4 | 2017 | 1590 | 0.200 |
Why?
|
Armadillo Domain Proteins | 1 | 2021 | 24 | 0.200 |
Why?
|
Phosphatidylinositol Phosphates | 2 | 2015 | 202 | 0.200 |
Why?
|
ras Proteins | 3 | 2016 | 1050 | 0.200 |
Why?
|
Blood-Brain Barrier | 2 | 2019 | 1017 | 0.200 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13268 | 0.200 |
Why?
|
Blotting, Western | 5 | 2020 | 5031 | 0.190 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2024 | 373 | 0.190 |
Why?
|
Mice, Inbred C57BL | 11 | 2022 | 21990 | 0.180 |
Why?
|
Toll-Like Receptor 9 | 1 | 2022 | 234 | 0.180 |
Why?
|
Phosphoglycerate Dehydrogenase | 1 | 2020 | 37 | 0.180 |
Why?
|
HEK293 Cells | 3 | 2021 | 4257 | 0.180 |
Why?
|
High-Throughput Screening Assays | 2 | 2016 | 933 | 0.180 |
Why?
|
Liver | 3 | 2013 | 7502 | 0.180 |
Why?
|
rac1 GTP-Binding Protein | 2 | 2016 | 242 | 0.170 |
Why?
|
Blood Glucose | 2 | 2015 | 6349 | 0.170 |
Why?
|
Tryptophan | 1 | 2022 | 480 | 0.170 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 4901 | 0.170 |
Why?
|
Mutation | 10 | 2023 | 29929 | 0.170 |
Why?
|
Mutation, Missense | 4 | 2015 | 2564 | 0.170 |
Why?
|
Oligonucleotides, Antisense | 1 | 2022 | 459 | 0.170 |
Why?
|
Cell Cycle Proteins | 3 | 2023 | 3434 | 0.170 |
Why?
|
Nucleic Acids | 1 | 2022 | 187 | 0.170 |
Why?
|
DNA, Complementary | 2 | 2018 | 1992 | 0.170 |
Why?
|
Phenylenediamines | 1 | 2019 | 86 | 0.160 |
Why?
|
Transcription Factor AP-1 | 1 | 2020 | 321 | 0.160 |
Why?
|
Gene Knockdown Techniques | 3 | 2020 | 1609 | 0.160 |
Why?
|
Thiazoles | 2 | 2018 | 1511 | 0.160 |
Why?
|
Estrogens | 2 | 2016 | 1519 | 0.160 |
Why?
|
Reverse Transcription | 1 | 2018 | 47 | 0.160 |
Why?
|
Lipids | 1 | 2010 | 3326 | 0.160 |
Why?
|
Alleles | 4 | 2018 | 6894 | 0.160 |
Why?
|
Frameshift Mutation | 1 | 2020 | 388 | 0.160 |
Why?
|
STAT3 Transcription Factor | 1 | 2023 | 869 | 0.160 |
Why?
|
Gene Knockout Techniques | 3 | 2019 | 802 | 0.160 |
Why?
|
Piperazines | 3 | 2018 | 2511 | 0.150 |
Why?
|
Mice, Inbred NOD | 2 | 2015 | 1824 | 0.150 |
Why?
|
Drug Design | 2 | 2018 | 1049 | 0.150 |
Why?
|
Lactic Acid | 1 | 2023 | 1133 | 0.150 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2018 | 180 | 0.150 |
Why?
|
Tumor Escape | 1 | 2020 | 369 | 0.140 |
Why?
|
Nerve Degeneration | 1 | 2021 | 748 | 0.140 |
Why?
|
DNA Damage | 2 | 2018 | 2439 | 0.140 |
Why?
|
Cell Survival | 3 | 2016 | 5781 | 0.140 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2017 | 1651 | 0.130 |
Why?
|
Neurons | 6 | 2017 | 9418 | 0.130 |
Why?
|
Receptors, Leptin | 1 | 2017 | 350 | 0.130 |
Why?
|
Autophagy | 2 | 2016 | 1321 | 0.130 |
Why?
|
Cytoskeletal Proteins | 1 | 2021 | 1342 | 0.130 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2017 | 263 | 0.130 |
Why?
|
RNA, Double-Stranded | 1 | 2017 | 295 | 0.130 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2021 | 709 | 0.130 |
Why?
|
Proto-Oncogene Proteins | 2 | 2010 | 4492 | 0.130 |
Why?
|
Protein Kinases | 3 | 2009 | 1608 | 0.130 |
Why?
|
Membrane Microdomains | 1 | 2016 | 206 | 0.130 |
Why?
|
MAP Kinase Signaling System | 2 | 2014 | 1477 | 0.120 |
Why?
|
Hypothalamus | 2 | 2011 | 998 | 0.120 |
Why?
|
Cyclin C | 1 | 2014 | 12 | 0.120 |
Why?
|
Peptide Library | 1 | 2016 | 347 | 0.120 |
Why?
|
Immunoconjugates | 1 | 2023 | 949 | 0.120 |
Why?
|
Thyroid Hormones | 1 | 2018 | 404 | 0.120 |
Why?
|
rac GTP-Binding Proteins | 1 | 2015 | 162 | 0.120 |
Why?
|
Energy Metabolism | 5 | 2017 | 2867 | 0.120 |
Why?
|
Neoplasms, Experimental | 1 | 2020 | 1228 | 0.120 |
Why?
|
Glucose Intolerance | 2 | 2010 | 575 | 0.120 |
Why?
|
Cell Line | 5 | 2015 | 15587 | 0.120 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 611 | 0.120 |
Why?
|
Insulin Resistance | 3 | 2015 | 3941 | 0.120 |
Why?
|
Cancer Vaccines | 1 | 2022 | 1046 | 0.120 |
Why?
|
Antigens, Viral, Tumor | 2 | 2012 | 153 | 0.120 |
Why?
|
Paclitaxel | 1 | 2021 | 1731 | 0.120 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 630 | 0.110 |
Why?
|
Uterus | 1 | 2018 | 649 | 0.110 |
Why?
|
Caspase 3 | 1 | 2016 | 728 | 0.110 |
Why?
|
Homeostasis | 5 | 2015 | 3299 | 0.110 |
Why?
|
Interferons | 1 | 2017 | 705 | 0.110 |
Why?
|
Myoblasts | 1 | 2015 | 232 | 0.110 |
Why?
|
Axons | 1 | 2021 | 1674 | 0.110 |
Why?
|
Glucagon-Like Peptide 2 | 1 | 2013 | 45 | 0.110 |
Why?
|
Histone Deacetylases | 1 | 2018 | 718 | 0.110 |
Why?
|
Viruses | 1 | 2017 | 376 | 0.110 |
Why?
|
Anticarcinogenic Agents | 1 | 2015 | 249 | 0.110 |
Why?
|
Prodrugs | 1 | 2015 | 259 | 0.110 |
Why?
|
Biological Assay | 1 | 2016 | 626 | 0.110 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2018 | 772 | 0.110 |
Why?
|
Conserved Sequence | 1 | 2016 | 1164 | 0.110 |
Why?
|
Genes, erbB-2 | 1 | 2013 | 162 | 0.110 |
Why?
|
MAP Kinase Kinase Kinases | 2 | 2012 | 256 | 0.110 |
Why?
|
Glioma | 2 | 2018 | 3417 | 0.100 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1334 | 0.100 |
Why?
|
Prostatic Intraepithelial Neoplasia | 1 | 2012 | 81 | 0.100 |
Why?
|
Chemotaxis | 1 | 2015 | 598 | 0.100 |
Why?
|
Eating | 2 | 2017 | 1536 | 0.100 |
Why?
|
Pyrimidinones | 1 | 2014 | 383 | 0.100 |
Why?
|
Receptor, erbB-3 | 1 | 2013 | 143 | 0.100 |
Why?
|
Sequence Alignment | 1 | 2016 | 2177 | 0.100 |
Why?
|
Androgen Receptor Antagonists | 1 | 2012 | 121 | 0.100 |
Why?
|
Genomic Instability | 1 | 2016 | 705 | 0.100 |
Why?
|
Antigen Presentation | 1 | 2017 | 1254 | 0.100 |
Why?
|
Receptor, Notch1 | 1 | 2014 | 494 | 0.100 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2018 | 1765 | 0.100 |
Why?
|
Lysine | 1 | 2016 | 993 | 0.100 |
Why?
|
Repressor Proteins | 2 | 2017 | 2976 | 0.100 |
Why?
|
Delayed-Action Preparations | 1 | 2015 | 961 | 0.090 |
Why?
|
Forkhead Transcription Factors | 3 | 2014 | 1610 | 0.090 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2015 | 621 | 0.090 |
Why?
|
NF-kappa B | 2 | 2018 | 2472 | 0.090 |
Why?
|
Adaptation, Physiological | 1 | 2018 | 1293 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2020 | 1584 | 0.090 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2017 | 3774 | 0.090 |
Why?
|
Genotype | 2 | 2017 | 12951 | 0.090 |
Why?
|
Neuropeptides | 1 | 2016 | 943 | 0.090 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 381 | 0.090 |
Why?
|
Drug Delivery Systems | 3 | 2017 | 2211 | 0.090 |
Why?
|
Fibroblast Growth Factors | 1 | 2016 | 866 | 0.090 |
Why?
|
Hypertension, Pulmonary | 1 | 2021 | 1565 | 0.090 |
Why?
|
DNA Repair | 2 | 2018 | 2038 | 0.090 |
Why?
|
Epidermis | 1 | 2013 | 528 | 0.090 |
Why?
|
Remission Induction | 1 | 2016 | 2390 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2016 | 1245 | 0.090 |
Why?
|
Indazoles | 1 | 2012 | 302 | 0.090 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2013 | 597 | 0.090 |
Why?
|
Pyrimidines | 2 | 2019 | 3005 | 0.090 |
Why?
|
Nanostructures | 1 | 2015 | 546 | 0.090 |
Why?
|
Erythropoiesis | 1 | 2014 | 682 | 0.090 |
Why?
|
Tumor Burden | 2 | 2013 | 1886 | 0.080 |
Why?
|
Protein Binding | 4 | 2016 | 9312 | 0.080 |
Why?
|
Bone Marrow | 2 | 2019 | 2908 | 0.080 |
Why?
|
Sequence Analysis, DNA | 1 | 2020 | 4710 | 0.080 |
Why?
|
Gene Silencing | 2 | 2017 | 1507 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 9245 | 0.080 |
Why?
|
Amino Acid Sequence | 3 | 2016 | 13442 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1795 | 0.080 |
Why?
|
Hedgehog Proteins | 1 | 2013 | 768 | 0.080 |
Why?
|
Phosphotransferases | 1 | 2009 | 302 | 0.080 |
Why?
|
Rats | 4 | 2021 | 23676 | 0.080 |
Why?
|
Transplantation, Heterologous | 2 | 2014 | 2378 | 0.080 |
Why?
|
Calcium | 1 | 2021 | 5720 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4550 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2020 | 2522 | 0.080 |
Why?
|
Drug Discovery | 1 | 2016 | 1044 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6470 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 2 | 2016 | 2800 | 0.080 |
Why?
|
Neural Stem Cells | 1 | 2015 | 883 | 0.080 |
Why?
|
Mesenchymal Stem Cells | 1 | 2018 | 1631 | 0.070 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2809 | 0.070 |
Why?
|
Dendritic Cells | 1 | 2018 | 2720 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2011 | 570 | 0.070 |
Why?
|
Phosphoproteins | 1 | 2016 | 2432 | 0.070 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2019 | 223 | 0.070 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 3432 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2020 | 15774 | 0.070 |
Why?
|
Cell Membrane | 1 | 2016 | 3680 | 0.070 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2009 | 410 | 0.070 |
Why?
|
Male | 18 | 2022 | 358180 | 0.070 |
Why?
|
Myristic Acid | 1 | 2005 | 49 | 0.070 |
Why?
|
Chromatin | 1 | 2018 | 2938 | 0.070 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6292 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2015 | 1623 | 0.070 |
Why?
|
I-kappa B Kinase | 1 | 2007 | 250 | 0.070 |
Why?
|
Histones | 1 | 2016 | 2570 | 0.060 |
Why?
|
Precipitin Tests | 2 | 2004 | 814 | 0.060 |
Why?
|
Up-Regulation | 1 | 2015 | 4110 | 0.060 |
Why?
|
Proteins | 2 | 2018 | 6024 | 0.060 |
Why?
|
Skin Neoplasms | 2 | 2016 | 5798 | 0.060 |
Why?
|
Neoplasm Invasiveness | 1 | 2013 | 3591 | 0.060 |
Why?
|
Epidermal Growth Factor | 1 | 2008 | 695 | 0.060 |
Why?
|
Prostate | 2 | 2022 | 1757 | 0.060 |
Why?
|
Sulfonamides | 2 | 2012 | 1972 | 0.060 |
Why?
|
Gene Deletion | 2 | 2017 | 2666 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2023 | 64242 | 0.060 |
Why?
|
Flow Cytometry | 1 | 2015 | 5861 | 0.060 |
Why?
|
Brain | 3 | 2021 | 26952 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2017 | 4407 | 0.060 |
Why?
|
Myocytes, Smooth Muscle | 2 | 2021 | 686 | 0.060 |
Why?
|
Sepsis | 1 | 2018 | 2579 | 0.060 |
Why?
|
Stress, Physiological | 1 | 2011 | 1399 | 0.060 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2017 | 3069 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2015 | 3602 | 0.060 |
Why?
|
Genome-Wide Association Study | 2 | 2020 | 12601 | 0.060 |
Why?
|
Agar | 1 | 2003 | 55 | 0.050 |
Why?
|
Molecular Weight | 1 | 2005 | 2185 | 0.050 |
Why?
|
Aspirin | 1 | 2015 | 3128 | 0.050 |
Why?
|
Neovascularization, Pathologic | 2 | 2015 | 2638 | 0.050 |
Why?
|
Anaphase | 1 | 2023 | 114 | 0.050 |
Why?
|
Fertility | 2 | 2018 | 771 | 0.050 |
Why?
|
Species Specificity | 1 | 2007 | 2413 | 0.050 |
Why?
|
Down-Regulation | 1 | 2010 | 2901 | 0.050 |
Why?
|
Mice, Inbred Strains | 2 | 2017 | 1758 | 0.050 |
Why?
|
Amino Acid Substitution | 1 | 2007 | 1733 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5786 | 0.050 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2003 | 436 | 0.050 |
Why?
|
Acylation | 1 | 2022 | 96 | 0.050 |
Why?
|
Metformin | 1 | 2010 | 905 | 0.050 |
Why?
|
Prostatic Neoplasms | 3 | 2012 | 11057 | 0.050 |
Why?
|
Transfection | 2 | 2016 | 5777 | 0.050 |
Why?
|
Drug Synergism | 2 | 2016 | 1746 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8654 | 0.050 |
Why?
|
Neovascularization, Physiologic | 1 | 2009 | 1332 | 0.050 |
Why?
|
Open Reading Frames | 2 | 2018 | 814 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2016 | 10749 | 0.050 |
Why?
|
DNA | 1 | 2015 | 7200 | 0.050 |
Why?
|
Stem Cells | 1 | 2014 | 3521 | 0.050 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2018 | 730 | 0.050 |
Why?
|
Lipopolysaccharides | 2 | 2019 | 2203 | 0.050 |
Why?
|
MicroRNAs | 1 | 2017 | 3780 | 0.050 |
Why?
|
Genes, Tumor Suppressor | 1 | 2005 | 1055 | 0.050 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2010 | 2052 | 0.050 |
Why?
|
Retroviridae | 1 | 2003 | 850 | 0.040 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2020 | 56 | 0.040 |
Why?
|
Genes, cdc | 1 | 2020 | 114 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 2 | 2021 | 8143 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 11890 | 0.040 |
Why?
|
Epilepsy | 1 | 2015 | 3270 | 0.040 |
Why?
|
Immunoblotting | 1 | 2003 | 1647 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3415 | 0.040 |
Why?
|
Adipocytes | 1 | 2006 | 1178 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 856 | 0.040 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2020 | 211 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2022 | 540 | 0.040 |
Why?
|
Neoplasm Metastasis | 1 | 2009 | 4886 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17767 | 0.040 |
Why?
|
Receptors, Androgen | 1 | 2004 | 1073 | 0.040 |
Why?
|
Estrus | 1 | 2017 | 70 | 0.040 |
Why?
|
Eicosapentaenoic Acid | 1 | 2022 | 560 | 0.040 |
Why?
|
Calcium Channels | 1 | 2021 | 618 | 0.040 |
Why?
|
Decidua | 1 | 2018 | 82 | 0.040 |
Why?
|
Obesity | 3 | 2016 | 12870 | 0.040 |
Why?
|
Transcription Factors | 3 | 2012 | 12092 | 0.040 |
Why?
|
Androgens | 1 | 2004 | 1281 | 0.040 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2017 | 186 | 0.040 |
Why?
|
Binding Sites | 1 | 2005 | 6034 | 0.030 |
Why?
|
Glycine | 1 | 2020 | 662 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2010 | 7982 | 0.030 |
Why?
|
Solubility | 1 | 2018 | 1087 | 0.030 |
Why?
|
Fluphenazine | 1 | 2016 | 35 | 0.030 |
Why?
|
RNA Interference | 3 | 2011 | 2834 | 0.030 |
Why?
|
Retinoblastoma-Binding Protein 2 | 1 | 2016 | 27 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 1036 | 0.030 |
Why?
|
Polyethylene Glycols | 1 | 2022 | 1188 | 0.030 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2020 | 788 | 0.030 |
Why?
|
Serine | 1 | 2020 | 828 | 0.030 |
Why?
|
Chlorpromazine | 1 | 2016 | 111 | 0.030 |
Why?
|
Gene Library | 2 | 2010 | 1059 | 0.030 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2018 | 346 | 0.030 |
Why?
|
Sexual Maturation | 1 | 2017 | 260 | 0.030 |
Why?
|
Imidazoles | 2 | 2012 | 1178 | 0.030 |
Why?
|
Embryo Implantation | 1 | 2018 | 270 | 0.030 |
Why?
|
Growth | 1 | 2017 | 365 | 0.030 |
Why?
|
Indans | 1 | 2016 | 92 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2018 | 6204 | 0.030 |
Why?
|
Cell Division | 1 | 2003 | 4459 | 0.030 |
Why?
|
Subcellular Fractions | 1 | 2016 | 532 | 0.030 |
Why?
|
Receptors, Dopamine | 1 | 2016 | 293 | 0.030 |
Why?
|
Dopamine Antagonists | 1 | 2016 | 288 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 2020 | 1996 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 3 | 1 | 2014 | 10 | 0.030 |
Why?
|
Docosahexaenoic Acids | 1 | 2022 | 905 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2018 | 6128 | 0.030 |
Why?
|
Methylamines | 1 | 2016 | 137 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2016 | 402 | 0.030 |
Why?
|
Cyclooxygenase 1 | 1 | 2015 | 97 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 8 | 1 | 2014 | 48 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2017 | 514 | 0.030 |
Why?
|
Neointima | 1 | 2015 | 133 | 0.030 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2016 | 425 | 0.030 |
Why?
|
Puberty | 1 | 2017 | 499 | 0.030 |
Why?
|
Fluorouracil | 1 | 2019 | 1636 | 0.030 |
Why?
|
DNA-Binding Proteins | 3 | 2012 | 9574 | 0.030 |
Why?
|
Receptor, Insulin | 1 | 2017 | 833 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2015 | 491 | 0.030 |
Why?
|
Benzimidazoles | 2 | 2012 | 855 | 0.030 |
Why?
|
Oligodendroglia | 1 | 2017 | 538 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2003 | 3379 | 0.030 |
Why?
|
Methylation | 1 | 2016 | 1078 | 0.030 |
Why?
|
Androgen Antagonists | 1 | 2022 | 1400 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2019 | 1752 | 0.030 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2013 | 203 | 0.030 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2017 | 618 | 0.030 |
Why?
|
Receptors, Glucagon | 1 | 2013 | 90 | 0.030 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2015 | 361 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2020 | 2190 | 0.030 |
Why?
|
Genes, BRCA2 | 1 | 2016 | 603 | 0.030 |
Why?
|
Proteomics | 2 | 2020 | 3809 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2018 | 3069 | 0.030 |
Why?
|
Castration | 1 | 2012 | 151 | 0.030 |
Why?
|
Keratinocytes | 1 | 2016 | 790 | 0.030 |
Why?
|
Genes, BRCA1 | 1 | 2016 | 765 | 0.030 |
Why?
|
Exons | 1 | 2018 | 2392 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2016 | 1788 | 0.020 |
Why?
|
Genetic Testing | 1 | 2005 | 3529 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2006 | 11469 | 0.020 |
Why?
|
Time Factors | 3 | 2019 | 39811 | 0.020 |
Why?
|
Phenols | 1 | 2015 | 514 | 0.020 |
Why?
|
Chromones | 1 | 2011 | 148 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2010 | 5815 | 0.020 |
Why?
|
KATP Channels | 1 | 2011 | 48 | 0.020 |
Why?
|
Genomics | 1 | 2007 | 5788 | 0.020 |
Why?
|
Phenylthiohydantoin | 1 | 2012 | 199 | 0.020 |
Why?
|
TRPC Cation Channels | 1 | 2011 | 110 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2010 | 6840 | 0.020 |
Why?
|
Metabolomics | 1 | 2020 | 1629 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2016 | 1073 | 0.020 |
Why?
|
Intracellular Membranes | 1 | 2011 | 389 | 0.020 |
Why?
|
Cathepsins | 1 | 2011 | 241 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2016 | 2056 | 0.020 |
Why?
|
Phagosomes | 1 | 2011 | 199 | 0.020 |
Why?
|
Protein Transport | 1 | 2016 | 1963 | 0.020 |
Why?
|
Models, Molecular | 2 | 2015 | 5406 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3510 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2010 | 202 | 0.020 |
Why?
|
Boron Compounds | 1 | 2011 | 180 | 0.020 |
Why?
|
Appetite Depressants | 1 | 2010 | 108 | 0.020 |
Why?
|
Hyperplasia | 1 | 2013 | 1153 | 0.020 |
Why?
|
Androstadienes | 1 | 2011 | 348 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2018 | 1516 | 0.020 |
Why?
|
Allosteric Regulation | 1 | 2010 | 426 | 0.020 |
Why?
|
Light | 1 | 2015 | 1344 | 0.020 |
Why?
|
Patch-Clamp Techniques | 1 | 2011 | 931 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36270 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 684 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2015 | 1486 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2009 | 384 | 0.020 |
Why?
|
Biphenyl Compounds | 1 | 2013 | 988 | 0.020 |
Why?
|
Disease Progression | 2 | 2019 | 13463 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2011 | 1094 | 0.020 |
Why?
|
Protein Subunits | 1 | 2011 | 942 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 640 | 0.020 |
Why?
|
Nitriles | 1 | 2012 | 950 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2011 | 1527 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2016 | 3734 | 0.020 |
Why?
|
Quinolines | 1 | 2012 | 758 | 0.020 |
Why?
|
Base Sequence | 1 | 2018 | 12437 | 0.020 |
Why?
|
Benzamides | 1 | 2012 | 1363 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2011 | 2496 | 0.020 |
Why?
|
Models, Animal | 1 | 2013 | 2110 | 0.020 |
Why?
|
Simian virus 40 | 1 | 2007 | 291 | 0.020 |
Why?
|
Quinazolines | 1 | 2013 | 1371 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 358 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3608 | 0.020 |
Why?
|
Lysosomes | 1 | 2011 | 918 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2016 | 2621 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2012 | 1986 | 0.020 |
Why?
|
Nanoparticles | 1 | 2017 | 1939 | 0.020 |
Why?
|
Genome, Human | 1 | 2018 | 4414 | 0.020 |
Why?
|
Body Weight | 1 | 2016 | 4602 | 0.020 |
Why?
|
Pyrazoles | 1 | 2015 | 1992 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5778 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 614 | 0.010 |
Why?
|
Kinetics | 1 | 2012 | 6371 | 0.010 |
Why?
|
Aneuploidy | 1 | 2007 | 550 | 0.010 |
Why?
|
Retinoblastoma Protein | 1 | 2007 | 670 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2015 | 3182 | 0.010 |
Why?
|
Karyopherins | 1 | 2003 | 132 | 0.010 |
Why?
|
Cell Movement | 1 | 2015 | 5196 | 0.010 |
Why?
|
Calmodulin | 1 | 2003 | 217 | 0.010 |
Why?
|
Two-Hybrid System Techniques | 1 | 2004 | 458 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16533 | 0.010 |
Why?
|
Skin | 1 | 2016 | 4464 | 0.010 |
Why?
|
Benzothiazoles | 1 | 2003 | 246 | 0.010 |
Why?
|
Indoles | 1 | 2010 | 1824 | 0.010 |
Why?
|
Dietary Fats | 1 | 2010 | 1991 | 0.010 |
Why?
|
Testosterone | 1 | 2012 | 2465 | 0.010 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2003 | 412 | 0.010 |
Why?
|
Pyridines | 1 | 2013 | 2864 | 0.010 |
Why?
|
Multigene Family | 1 | 2004 | 1076 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 6070 | 0.010 |
Why?
|
Adult | 3 | 2021 | 219725 | 0.010 |
Why?
|
Gene Expression | 1 | 2013 | 7584 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20037 | 0.010 |
Why?
|
Cohort Studies | 1 | 2023 | 41190 | 0.010 |
Why?
|
Telomerase | 1 | 2004 | 745 | 0.010 |
Why?
|
Child | 2 | 2018 | 79782 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2004 | 2750 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36045 | 0.010 |
Why?
|
Genome | 1 | 2007 | 1739 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 54092 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2005 | 1956 | 0.010 |
Why?
|
Algorithms | 1 | 2017 | 13952 | 0.010 |
Why?
|
Pregnancy | 1 | 2018 | 29712 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2003 | 2903 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 79984 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 58558 | 0.010 |
Why?
|
Risk Assessment | 1 | 2015 | 23816 | 0.010 |
Why?
|
Middle Aged | 2 | 2019 | 219192 | 0.010 |
Why?
|
Melanoma | 1 | 2010 | 5689 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 17615 | 0.010 |
Why?
|
Aged | 1 | 2019 | 167890 | 0.000 |
Why?
|